Antiretroviral Agents in HIV-1 (2018)

Antiretroviral Agents in HIV-1 Pocket Guide

DHHS HIV GUIDELINES Apps brought to you free of charge courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/370315

Contents of this Issue

Navigation

Page 3 of 29

4 Selecting a Treatment Regimen HIV-Infected Adolescents and Young Adults Î Adolescents living with HIV largely belong to two distinct groups— those who acquired HIV in infancy and are heavily ART-experienced, and those who acquired HIV more recently during their teens. Î ART is recommended for all HIV-infected individuals (A-I) to reduce morbidity and mortality. Thus, ART is also recommended for ART- naive adolescents. However, before initiation of therapy, adolescents' readiness and ability to adhere to therapy within their psychosocial context need to be carefully considered as part of therapeutic decision making (A-III). Î Once ART is initiated, appropriate support is essential to reduce potential barriers to adherence and maximize the success in achieving sustained viral suppression (A-II). Î The adolescent sexual maturity rating can be helpful to guide regimen selection for initiation of or changes in ART as recommended by either the Adult and Adolescent ART Guidelines or the Pediatric ART Guidelines. The Adult/Adolescent Guidelines are more appropriate for postpubertal adolescents (i.e., sexual maturity rating IV or V) (A-III). Î Pediatric and adolescent care providers should prepare adolescents for the transition into adult care settings. Adult providers should be sensitive to the challenges associated with such transitions, consulting and collaborating with care providers for adolescents with HIV to ensure adolescents' successful transition and continued engagement in care (A-III).

Articles in this issue

Archives of this issue

view archives of Antiretroviral Agents in HIV-1 (2018) - Antiretroviral Agents in HIV-1 Pocket Guide